Using social media — the right way — can help foster better relationships with millennial clients. Tracy Le Blanc/Pexels

According to a 2018 AdWeek article by Dario Cardile, the millennial population accounts for 66 percent of the first-time homebuyer's market, and industry research suggests the millennial generation chooses Instagram as its top social media platform.

I have learned the importance of adapting to modern techniques including adopting the social media climate and using it to my advantage, both as an individual and as a company. It's not just because social media has grown to be a leading component of brand promotion but because it's my direct line of communication to my current and future clients.

Today, social media, particularly Instagram, is not just a small promotional tool among many, but rather a major engagement platform for the real estate industry. As a real estate agent in the competitive Houston market, I use Instagram as another avenue to reach a larger audience, connect with potential new clients and showcase my listings in a unique and organic way that complements my overall approach.

I have found that my Instagram followers enjoy seeing both sides of me: the professional and personal. Keeping up with my account isn't as simple as posting every so often. People like to know and trust who they are working with and it's been a fun challenge to balance (and blur) my work and personal life to give my followers and clients a behind-the-scenes look at my career and lifestyle. I've learned that they want to know who you are in and out of the office and I've even been asked for tips outside of real estate such as make up, skincare, and fitness.

One way I organize my Instagram account is through categorized story highlights. Because I post frequent stories, it's important to feature and distinguish the most notable ones in order for people to find what they are looking for, whether it be things I have to offer as a Realtor or what I do in my free time. I've created story categories such as "Listings," "Nan Properties," "Fitness," "Beauty," and "In the News" in order for easy access.

My posts on my feed often feature pictures of me in both the work and social environment. I like to create fun captions that encourage followers to check out my story in order to see the latest listings. This makes the work aspect of my life exciting and engaging.

Because real estate is very focused on visual content, videos and photos of listings provide a quick and convenient way for clients to view listed properties. This engagement is incredibly important to keep my real estate company top-of-mind for clients, especially those who are millennials. In addition, I feature pictures of my family and adorable puppy in order to show my followers what is important in my life.

Of course, it's necessary to set boundaries when it comes to sharing personal information on social media. I've taken a lot of precautions when it comes to sharing my personal life and my biggest rule is to avoid sharing in real time when possible.

A major tip that I would pass on to any Realtors or client-focused professionals getting involved with social media is to have fun. People love to see your excitement about what you do. Be consistent with your posts and as more followers engage with your content, take note of what they enjoy and would like to see you posting about frequently.

------

Nancy Almodovar is the president and CEO of Nan and Company Properties in Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”